Skip to content

The effect and mechanism of iron status and hepcidin concentrations of patients with cervical cancer on chemoradiotherapy treatment

The effect and mechanism of iron status and hepcidin concentrations of patients with cervical cancer on chemoradiotherapy treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089741
Enrollment
Unknown
Registered
2024-09-14
Start date
2024-09-16
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

case series:none

Sponsors

Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Pathologically and radiologically confirmed cervical cancer patients with a clearly defined stage; 2. FIGO staging II-III; 3. Patients scheduled for radiotherapy/radiochemotherapy; 4. Aged 18 years or older; 5. Able to communicate normally, without reading or writing difficulties, psychiatric disorders, or cognitive impairments, and willing to participate in this study.

Exclusion criteria

Exclusion criteria: 1. Coexist with other primary tumors; 2. Presence of severe systemic diseases

Design outcomes

Primary

MeasureTime frame
Ferritin;Plasam iron;Transferrin;Soluble transferrin receptor;Body composition analysis ;The Response Evaluation Criteria in Solid Tumours (version 1.1);Transferrin saturation;Total Iron Binding Capacity;

Secondary

MeasureTime frame
Anthropometric Indicators;Food Frequency Questionnaire;Quality of life questionnaire for cancer patients;Common Terminology Criteria for Adverse Events;Toxicity criteria of the Radiation Therapy Oncology Group;Physical activity;Nutritional risk screening 2002;Patient-generated subjective globe assessment;Albumin;C-reactive protein;Blood glucose;Biomarkers of cervical cancer;Blood routine examination;Plasma triglyceride;Karnofsky Performance Status (KPS) questionnaire;hand grip strength ;

Countries

China

Contacts

Public ContactXu Zhang

Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital

zhangxutjmu@zzu.edu.cn+86 159 7212 2511

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026